-- 独立系調査会社CFRAは、に対し、以下の調査レポートを提供しました。CFRAのアナリストは、以下のように見解をまとめています。CF Industriesは、第1四半期に好調な業績を達成しました。1株当たり利益（EPS）は前年同期の1.85ドルに対し3.98ドルとなり、市場予想の2.66ドルを上回りました。調整後EBITDAは53%増の9億8,300万ドルとなり、市場予想の7億7,400万ドルを上回りました。純売上高は19%増の19億9,000万ドルとなり、市場予想の18億6,000万ドルを上回りました。これは、ヤズーシティ工場の操業停止による販売量減少を、全事業セグメントにおける堅調な価格設定が相殺したためです。アンモニア生産能力の99%という卓越した操業実績と、制約の多い世界の窒素市場における戦略的なポジショニングは、投資判断を裏付けるものです。経営陣は、2026年通年のアンモニア総生産量を約950万トンと予測しており、ヤズーシティの操業再開は2026年第4四半期後半まで見込まれていません。中東紛争による地域生産能力の50～60%への影響や、輸入依存地域におけるLNG供給制約を考慮すると、世界的な需給バランスの逼迫は今後も続くと予想されます。CFの低炭素イニシアチブ、特にブルーポイント合弁事業やヤズーシティCCSプロジェクトは、長期的な価値創造のための構造的な優位性をもたらします。
Related Articles
Australia
CVS Health Increasingly Likely to Reach 3% Medicare Advantage Target Margin in 2028, RBC Says
CVS Health (CVS) is increasingly more likely to reach its 3% Medicare Advantage target margin in 2028, RBC Capital Markets analyst said in a note Wednesday.Analysts said the company's Q1 adjusted earnings "comfortably" beat expectations, driven by "strong" topline growth and a notable improvement in profitability in the Health Care Benefits segment.Medical costs came in below expectations and, while the company maintained its medical benefit ratio guidance for the year, it is increasingly likely to outperform, according to the note.The brokerage raised its 2026 adjusted earnings estimate for the company to $7.41 from $7.10. Analysts surveyed by FactSet expect $7.29.RBC reiterated its outperform rating on the stock and increased its price target to $107 from $93.Price: $87.01, Change: $+0.14, Percent Change: +0.17%
$CVS
Research
Research Alert: CFRA Maintains Strong Buy Rating On Shares Of Trimble Inc.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We increase our target price to $86, from 85, on a forward P/E of 21x our 2027 EPS projection of $4.08, below historical averages. We increase our 2026 EPS projection to $3.59 from $3.52, and lift our 2027 EPS estimate to $4.08 from $4.06. TRMB reported solid Q1 beats with revenue of $939.9M, up 12% Y/Y, led by AECO at 14% organic revenue and ARR growth, Field Systems posting 12% growth, and Transportation & Logistics growing 7% despite freight market headwinds. ARR reached a record $2.435B, up 13% organically, reinforcing business model durability. Non-GAAP operating margin improved 230 bps to 25.9%, while non-GAAP gross margins expanded 180 bps to 71.0%, and we see continued margin expansion as its subscription revenues scale. We note steady execution in its core business, while building AI momentum through new products and partnerships with AI labs. Management reaffirmed its 2027 targets, supporting our positive view, though macro risks warrant monitoring.
$TRMB
Australia
Apollo Global Trades at Lower Discount Versus Peers, RBC Says
Apollo Global Management (APO) shares are trading in-line with historical average multiple and at a lower discount against its peers, RBC Capital Markets said in a Thursday note."We maintain our Sector Perform rating largely driven by relative valuation," the report said.The note said its Q1 performance was characterized by strong fee-related earnings growth, offset by weak spread-related earnings growth, driving a low adjusted net income per share growth.RBC raised its price target to $146 from $139 on rolling forward its valuation and higher estimates.Price: $127.33, Change: $-2.20, Percent Change: -1.70%
$APO